Research Director
Elizabeth Lee Lewandrowski is on the faculty of the Department of Pathology at the Massachusetts General hospital in Boston, Massachusetts and serves as a Clinical Laboratory Scientist in Chemistry. She is an Assistant professor of Pathology at Harvard Medical School. Dr Lee-Lewandrowski received her Ph.D in Chemistry from Brown University and her MPH from the Harvard School of Public health. She joined the staff of the Massachusetts General Hospital in 1999.
Her research interests are focused on the clinical applications of point-of-care testing technologies to improve outcomes and the efficiency of clinical operations. Dr. Lee-Lewandrowski has recently been conducting research and directing continuing education conferences (2014, 2016 and 2019) on Lyme disease and other tick-borne infections. In the past year she published two large epidemiological studies documenting changing trends in tick-borne diseases locally and at the national level. A third paper documenting national trends in non-Lyme tick-borne infections was recently published.
Invisible International, Inc. is a MA nonprofit corporation operating through a fiscal sponsorship with Players Philanthropy Fund, a Maryland charitable trust recognized by IRS as a tax-exempt public charity under Section 501(c)(3) of the Internal Revenue Code (Federal Tax ID: 27-6601178). Contributions to Invisible International are tax-deductible to the fullest extent of the law.